Volume 25, issue 3, Mars 2018

Éditorial

Treatment of rare peritoneal tumours: a role for RENAPE network (peritoneal paramyxoma) (p.226-9)
Frédéric Bibeau, François-Noël Gilly, Olivier Glehen, Laurent Villeneuve
Free Access

Mini-revues

Systemic treatment of hepatocellular carcinoma: sorafenib is no longer alone! (p.230-7)
Astrid de Maissin, Jérôme Gournay, Tamara Matysiak-Budnik, Jaafar Bennouna, Maëva Salimon, Yann Touchefeu
Free Access

Recent advances in hepatotoxicity of non-steroidal anti-inflammatory drugs (p.238-47)
Lucy Meunier, Dominique Larrey
Free Access

Evolution of the treatment of colorectal liver metastases: toward a definition of parenchyma saving procedures (p.248-55)
Serge Evrard
Free Access

Gastrointestinal toxicity induced by checkpoint inhibitors: anti-CTLA-4 and anti-PD-1/PDL-1 antibodies (p.256-65)
Clélia Coutzac, Caroline Robert, Michael Collins, Emilie Soularue, Alice de Malet, Lysiane Marthey, Patricia Lepage, Nathalie Chaput, Franck Carbonnel
Free Access

Lymphoproliferative disorders in Inflammatory Bowel Diseases (p.266-76)
Mathieu Uzzan, Gilles Boschetti, Gildas Phelip, Marion Chauvenet, Xavier Roblin, Bernard Flourié, Stéphane Nancey
Free Access

Surgical treatment of ulcerative colitis (p.277-84)
Antoine Cazelles, David Moszkowicz
Free Access

Point de vue

What place for the adenoma detection rate in a colorectal cancer screening program? (p.285-92)
Patrice Pienkowski
Free Access

Lecture

Il était un Foie (p.293)
Philippe Lévy
Free Access

Injections de rappel

à retenir Du n^o 2 février 2018 (p.294-5)

Free Access